193902-81-7Relevant articles and documents
PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER
-
, (2021/04/23)
The invention provides compounds of the formula (1): or a salt or tautomer thereof wherein A, R1, R2, R3, R4, R5 and R6 are as defined herein. The compounds are inhibitors of Wee1 and/or PLK1 kinase and are envisaged to be useful in the treatment of cancers.
BICYCLIC CARBOXAMIDE INHIBITORS OF KINASES
-
, (2012/08/07)
Compounds of formula (I) or pharmaceutical acceptable salts are provided, wherein X1~X5, R1~R3, A, B, Z and n are defined in the description. And compositions containing said compounds, and the uses for inhibitors of kinases such as ALK, and the uses for treating cancer thereof are provided.
The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists
Lunniss, Gillian E.,Barnes, Ashley A.,Barton, Nick,Biagetti, Matteo,Bianchi, Federica,Blowers, Stephen M.,Caberlotto, Laura,Emmons, Amanda,Holmes, Ian P.,Montanari, Dino,Norris, Ros,Walters, Dewi J.,Watson, Steve P.
scheme or table, p. 4022 - 4025 (2010/03/30)
A novel small molecule NPY Y2 antagonist (3) identified from high throughput screening is described. A subsequent SAR study and optimisation programme based around this molecule is also described, leading to the identification of potent and soluble pyridyl analogue 36.